AGER and cancer: The receptor for advanced glycation-end products (RAGE) is a multiligand receptor of the immunoglobulin superfamily, involved in physiological (e.g., cell proliferation, differentiation, and survival) and pathological (e.g., neurodegeneration, inflammation, and cancer) processes [5].